Management of patients and side effects during cyclosporine therapy for cutaneous disorders

The document discussed the management of patients undergoing cyclosporine therapy for cutaneous disorders, focusing on monitoring and mitigating side effects. Cyclosporine, an immunosuppressive drug, was effective in treating various skin conditions but came with potential adverse effects such as nephrotoxicity, hypertension, and increased risk of infections. The paper emphasized the importance of regular monitoring of kidney function, blood pressure, and overall patient health to minimize these risks. It also highlighted the need for individualized dosing and careful patient selection to optimize therapeutic outcomes while reducing side effects.